Activity Coaching in Patients Post Lung Transplantation
Enhancing Physical Activity in Patients After Lung Transplantation: Effectiveness and Feasibility of a Semi-automated Tele Coaching Program
1 other identifier
interventional
108
1 country
1
Brief Summary
Lung transplantation is an ultimate, effective treatment option for selected patients with end stage lung disease, improving quality of life and extending survival. Because of the improved survival during the last decades, enhancing the long term condition after lung transplantation has now become a focus for disease management. The co-presence of non-communicable diseases is common and poses new challenges to disease management. These comorbidities have been related to physical activity in the healthy population. As in other chronic respiratory disease, physical inactivity is a common feature of patients after LTX. Despite near normal lung function, exercise intolerance and physical inactivity persist up to years after the transplantation. Literature on effective interventions to increase physical activity are scarce in this population. Therefore, the present project aims to test the effectiveness of a tele coaching program to enhance physical activity and to analyze the association between physical activity and long-term health benefits in this population at risk. These research questions will be answered based on a randomized controlled trial. Patients that are active at baseline will be followed up in a cohort study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 16, 2019
CompletedFirst Posted
Study publicly available on registry
October 10, 2019
CompletedStudy Start
First participant enrolled
November 6, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 7, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 7, 2023
CompletedFebruary 13, 2024
February 1, 2024
3.8 years
May 16, 2019
February 12, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Daily number of steps at 12 weeks (short term effect)
Change in daily mean step count 12 weeks post randomization in the intervention group as compared to the control group. Physical activity will be objectively measured for 1 week using a tri-axial accelerometer validated for use in in chronic respiratory disease. Data obtained on days with more than 8 hours of wearing time will be used for further analysis.
12 weeks
Secondary Outcomes (22)
Proportion of responders
12 weeks and 52 weeks
Daily number of steps at 52 weeks (long term effect)
52 weeks
Exercise capacity
12 weeks and 52 weeks
Quadriceps force
12 weeks and 52 weeks
Health related quality of life
12 weeks and 52 weeks
- +17 more secondary outcomes
Study Arms (2)
Tele coaching group
EXPERIMENTALCoaching with daily interaction with the coaching application, based on an adaptive physical activity goal
Sham coaching group
SHAM COMPARATORCoaching with fixed physical activity goal and limited interaction with the smartphone application.
Interventions
A.Education about the importance of PA. During a one-to-one interview with the coach motivation, self-efficacy, barriers, favorite activities and strategies to become more active are discussed. B. Step counter providing direct feedback. C.A smartphone with a project-tailored application. The application provides automated coaching by displaying an activity goal (number of steps) and feedback on a daily basis. The feedback comes with a graphical presentation. Patients' targets are automatically revised weekly. The aim is to progressively increase the PA during the 12 weeks period and maintain afterwards. D.Telephone contacts triggered in the case of non-compliance with wearing the step counter, failure to transmit data or failure to progress. Coaches are alerted by a note at the coaches' backend to take contact with the patient if needed.
A. Education about the importance of PA. During a one-to-one interview with the investigator, patients will receive a personal goal (expressed in steps/day), based on their individual exercise capacity. B.A step counter providing direct feedback. C.A smartphone with a project-tailored application. The application receives the step data of the patient and asks on a weekly basis about the patient's change in medication. The application does provide a graph showing the steps the patient took and presents a general activity plan including their personal goal (which stays the same throughout the entire intervention period).
Eligibility Criteria
You may qualify if:
- Stable patients at least 6 months and maximum 4 years after the first double lung transplantation
- Older than 30 years
- Understand and able to work with the smartphone application, as judged by the investigator
You may not qualify if:
- Having a diagnosis of Cystic Fibrosis
- Musculoskeletal problems not allowing a normal gait pattern
- Receiving a multi-organ transplantation or previously undergoing a solid-organ or bone marrow transplantation
- Having a life expectancy \<1year
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- KU Leuvenlead
Study Sites (1)
KULeuven
Leuven, 3000, Belgium
Related Publications (1)
Breuls S, Blondeel A, Wuyts M, Verleden GM, Vos R, Janssens W, Troosters T, Demeyer H. 1-year physical activity coaching programme in lung transplant recipients: an RCT. Thorax. 2025 Sep 15;80(10):711-719. doi: 10.1136/thorax-2024-222896.
PMID: 40447328DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thierry Troosters, Prof
KU Leuven
- PRINCIPAL INVESTIGATOR
Heleen Demeyer, Dr
KU Leuven
- PRINCIPAL INVESTIGATOR
Wim Janssens, Prof
KU Leuven
- PRINCIPAL INVESTIGATOR
Robin Vos, Prof
KU Leuven
- PRINCIPAL INVESTIGATOR
Daniel Langer, Prof
KU Leuven
- PRINCIPAL INVESTIGATOR
Geert Verleden, Prof
KU Leuven
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Patients in the control group will receive a sham version of the smartphone application
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
May 16, 2019
First Posted
October 10, 2019
Study Start
November 6, 2019
Primary Completion
September 7, 2023
Study Completion
September 7, 2023
Last Updated
February 13, 2024
Record last verified: 2024-02